A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 789-794

  Damsbo, Peter ^a   Clauson, Per ^a   Marbury, Thomas C ^b   Windfeld, Kristian ^a  

^a NOVO NORDISK A S   (Denmark)

^b ORLANDO CLINICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; REPAGLINIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIET; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; CARBAMATES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EATING; ENERGY INTAKE; FASTING; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; PIPERIDINES;

EID: 0032945023     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.789     Document Type: Article

References (22)

1. Warren JH, Rich SS, Krolewski AS: Epidemiology and genetics of diabetes mellitus. In Joslin's Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1995, p. 201-215
2. Barnard RJ, Jung T, Inkeles SB: Diet and exercise in the treatment of NIDDM: the need for early emphasis. Diabetes Care 17:1469-1472, 1994
3. Melander A: Oral antidiabetic drugs: an overview. Diabet Med 13:S143-S147, 1996
4. Wåhlin-Boll E, Almér L-O, Melander A: Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics. Clin Pharmacokinet 7:363-372, 1982
5. Gerich J: Drug therapy: oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
6. Chow C-C, Tsang LWW, Sorensen JP, Cockram CS: Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure of type 2 diabetes patients. Diabetes Care 18:307-314, 1995
7. Genuth S: Management of the adult onset diabetic with sulfonylurea drug failure. Endocrinol Metab Clin North Am 21:351-370, 1992
8. Profozic V, Babic D, Renar I, Rupprecht E, Skrabalo Z, Metolko Z: Benzoic acid derivative hypoglycemic activity in non-insulin dependent diabetic patients (Abstract). Diabetologia 36 (Suppl. 1):701, 1993
9. Kikuchi M: Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycemic agents, NN623 and A4166. Diabet Med 13:5151-5155, 1996
10. Fuhlendorff J, Kofod H, Shymko R, Carr RD, Rorsman P: Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47:345-351, 1998
11. Damsbo P, Andersen PH, Lund S, Schmitz O: Improved glycemic control with repaglinide in NIDDM with 3 times daily meal-related dosing (Abstract). Diabetes 46 (Suppl. 1):34A, 1997
12. Wolfenbuttel BHR, Nijst L, Sels JPJE, Menheere PPCA, Müller PG, Nieuwenhuijzen Kruseman AC: Effects of a new oral hypoglycemic agent, repaglinide, on metabolic control in sulfonylurea-treated patients with type 2 diabetes. Eur J Clin Pharmacol 45:113-116, 1993
13. Kahn CR: Banting Lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
14. Polonsky KS, Stuns J, Bell GI: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777-783, 1996
15. Alzaid AA: Insulin resistance in non-insulin-dependent diabetes mellitus. Acta Diabetol 33:87-99, 1996
16. Mooradian AD: Drug therapy of non-insulin-dependent diabetes mellitus in the elderly. Drugs 51:931-941, 1996
17. Bloomgarden ZT: New and traditional treatment of glycemia in NIDDM. Diabetes Care 19:295-299, 1996
18. Lalau J-D: Prevention of microvascular and neurological complications of diabetes: results of the DCCT (diabetes control and complications trial). Sang Thrombose Vaisseaux 8:475-482, 1996
19. Kollros PR, Knokle BA: Microvascular disease in diabetes mellitus. Coron Artery Dis 7:702-707, 1996
20. Fuller JH, Stevens LK, Wang S-L: International variations in cardiovascular mortality associated with diabetes mellitus: the WHO multinational study of vascular disease in diabetes. Ann Med 28:319-322, 1996
21. Babiker IE, Jerrom DWA, McInerney D, Hartog M: Compliance with glibenclamide treatment in non-insulin-dependent diabetic patients. Practical Diabetes 8:149-150, 1991
22. Murphy E, Kinmonth AL: No symptoms, no problems? Patients' understandings of non-insulin dependent diabetes. Fam Pract 12:184-192, 1995